Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387374
Status:
COMPLETED
Last Update Posted:
2013-01-17
First Post:
2006-10-12
Brief Title:
Radiation Therapy Bevacizumab Paclitaxel and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Adenosquamous Cell Lung Cancer |
| DrugAgent Toxicity by TissueOrgan |
| Hemoptysis |
| Squamous Cell Lung Cancer |
| Stage IIIB Non-small Cell Lung Cancer |
Keywords: